Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AdvancePCS Sees Little Chance For Medicare Rx In 2001

Executive Summary

The odds of a Medicare prescription drug benefit becoming law this year are very slim, AdvancePCS CEO David Halbert told the Goldman Sachs healthcare conference in Dana Point, Calif., July 13.

You may also be interested in...


HHS lacks authority to approve Vermont Pharmacy Discount Program demonstration project extending Medicaid drug rebate structure to 70,000 beneficiaries without drug coverage, D.C. federal appeals court rules June 8. The opinion reverses Jan. 18 D.C. federal court decision denying the Pharmaceutical Research & Manufacturers of America's request for a preliminary injunction against the program (1"The Pink Sheet" Jan. 29, p. 7). "Because Congress imposed the rebate requirement in order to reduce the cost of the Medicaid program, and because no Medicaid funds are expended under the Vermont demonstration project and thus no Medicaid savings produced by the required rebates, we conclude that the department lacked the authority to approve the project," the appeals court says

Caremark PBM Services Could Reduce Senior Rx Costs By 26.5%, Firm Says

Caremark's PBM services could reduce an uninsured senior citizen's average annual pharmaceutical spending by 26.5%, the company told a June 5 securities analysts meeting at its new Mount Prospect, Ill. mail order pharmacy.

Florida Medicaid Rebates To Be Negotiated By Provider Synergies

Florida Medicaid's supplemental rebate negotiations will be conducted by the pharmaceutical contracting firm Provider Synergies.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts